Ursochol (Ursodiol) Hart hylki 250 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

ursochol (ursodiol) hart hylki 250 mg

orifarm generics a/s - acidum ursodeoxycholicum inn - hart hylki - 250 mg

Albuman Innrennslislyf, lausn 200 g/l আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

albuman innrennslislyf, lausn 200 g/l

prothya biosolutions netherlands b.v. - human serum albumin - innrennslislyf, lausn - 200 g/l

Albuman Innrennslislyf, lausn 40 g/l আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

albuman innrennslislyf, lausn 40 g/l

prothya biosolutions netherlands b.v. - human albumin - innrennslislyf, lausn - 40 g/l

VaxigripTetra Stungulyf, dreifa í áfylltri sprautu 15 míkróg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

vaxigriptetra stungulyf, dreifa í áfylltri sprautu 15 míkróg

sanofi pasteur* - a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2) - líkur stofn (a/darwin/9/2021, ivr-228); b/austria/1359417/2021 - líkur stofn (b/michigan/01/2021, villigerð); b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð) - stungulyf, dreifa í áfylltri sprautu - 15 míkróg

Vyndaqel ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

vyndaqel

pfizer europe ma eeig - tafamidis - amyloidosis - Önnur lyf í taugakerfinu - vyndaqel er ætlað fyrir meðferð transthyretin amyloidosis í fullorðinn sjúklinga með stigi-1 einkennum polyneuropathy að tefja útlæga taugasköddun skert.

Alburex Innrennslislyf, lausn 200 g/l আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

alburex innrennslislyf, lausn 200 g/l

csl behring gmbh* - human albumin - innrennslislyf, lausn - 200 g/l

Alburex Innrennslislyf, lausn 50 g/l আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

alburex innrennslislyf, lausn 50 g/l

csl behring gmbh* - human serum albumin - innrennslislyf, lausn - 50 g/l

Zejula ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - Æxlishemjandi lyf - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

Evrysdi ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

evrysdi

roche registration gmbh  - risdiplam - vöðvaáfall, mænu - Önnur lyf við sjúkdómum í stoðkerfi - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.

Zoledronic acid Teva Generics ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

zoledronic acid teva generics

teva generics b.v - zoledronsýru einhýdrat - osteoporosis; osteitis deformans - bisfosfónöt - meðferð osteoporosisin tíðahvörf womenin fullorðinn menat jókst hættan á beinbrot, þar með talið lágt undanfarna-áverka mjöðm beinbrot. meðferð beinbrot í tengslum við langtíma almenn sykurstera therapyin tíðahvörf womenin fullorðinn menat jókst hættan á beinbrot. meðferð gerðar voru á fyrirbyggjandi er sjúkdómur bein í fullorðnir.